Trial Profile
A Retrospective Study Assessing the Efficacy and Safety of Ripasudil Hydrochloride Hydrate in Patients with Uveitic Glaucoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- 18 May 2018 New trial record
- 01 Apr 2018 Results published in the Graefes Archive for Clinical and Experimental Ophthalmology.